Barbara Davis Center — Aurora, Colorado

Public research footprint of Barbara Davis Center, compiled from the ClinicalTrials.gov public registry.

195

Registered studies

Active

Recruiting now

139

Completed

Stopped or withdrawn

Most-studied conditions

Type 1 Diabetes Mellitus · T1DM · T1D · Type 2 Diabetes Mellitus

Recently updated registry entries

NCT05574335 — Siplizumab in T1DM (Terminated)
NCT06783309 — CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6… (Recruiting)
NCT07720388 — Supporting Medtronic 780G Insulin Pump Adoption in Latino Patients: A Spanish - Language… (Not Yet Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Barbara Davis Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.